[EN] HYDROXAMATE COMPOUNDS AS ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR<br/>[FR] COMPOSÉS HYDROXAMATE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR A2A DE L'ADÉNOSINE
申请人:ADORX THERAPEUTICS LTD
公开号:WO2020260857A1
公开(公告)日:2020-12-30
The present invention relates to compounds of formula I shown below: (I) wherein R1, R2 and R3 are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a receptor activity is implicated, such as, for example, cancer.
本发明涉及下面所示的式I的化合物:(I),其中R1、R2和R3在申请中各自定义。本发明还涉及制备这些化合物的方法,包括含有它们的药物组合物,以及它们在治疗腺苷A2a受体活性参与的疾病或症状中的用途,例如癌症。